Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Bao

Showing results (681-690 of 694) with videos related to

Pageof 70
Sort By:
Cancer Medicine|June 4, 2020
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort studyJie-Jing Qian, Xiaoxia Hu, Ying Wang, et al.
Frontiers in Pharmacology|July 2, 2025
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibodyJia-Xin Li, Shi-Yu Tan, Li-Qi Li, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2026
First large-scale screening of Notch biallelic variants implicates novel candidate genes in congenital hypothyroidismFeng-Yao Wu, Chen-Yang Wu, Zheng Wang, et al.
Diabetes, Obesity & Metabolism|January 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation studyGui-Ling Chen, Yang Liu, Xue-Feng Gao, et al.
Journal of Ethnopharmacology|April 10, 2022
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trialHuan-Ming Xiao, Mei-Jie Shi, Jun-Min Jiang, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
Gut|May 27, 2018
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trialQian Chen, Chang Shu, Arian D Laurence, et al.
Journal of Digestive Diseases|November 3, 2022
The neutrophil-to-lymphocyte ratio represents a systemic inflammation marker and reflects the relationship with 90-day mortality in non-cirrhotic chronic severe hepatitisFu Chen Dong, Wen Ting Tan, Xian Bo Wang, et al.
World Journal of Gastroenterology|September 26, 2022
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in ChinaZi-Xuan Shen, Dan-Dan Wu, Jie Xia, et al.
Eclinicalmedicine|February 24, 2023
Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort studyLi Yuan, Lin Yang, Shichuan Zhang, et al.
Pageof 70

Showing results (681-690 of 694) with videos related to

Sort By:
Pageof 70
Cancer Medicine|June 4, 2020
CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort studyJie-Jing Qian, Xiaoxia Hu, Ying Wang, et al.
Frontiers in Pharmacology|July 2, 2025
Tricin selectively combats KRAS-mutant non-small cell lung cancer by inhibiting the PDGF-BB-induced SRC/MAPK/AP-1/PD-L1 signaling pathway and potentiating the antitumor effect of an anti-PD-1 antibodyJia-Xin Li, Shi-Yu Tan, Li-Qi Li, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2026
First large-scale screening of Notch biallelic variants implicates novel candidate genes in congenital hypothyroidismFeng-Yao Wu, Chen-Yang Wu, Zheng Wang, et al.
Diabetes, Obesity & Metabolism|January 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation studyGui-Ling Chen, Yang Liu, Xue-Feng Gao, et al.
Journal of Ethnopharmacology|April 10, 2022
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trialHuan-Ming Xiao, Mei-Jie Shi, Jun-Min Jiang, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
Gut|May 27, 2018
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trialQian Chen, Chang Shu, Arian D Laurence, et al.
Journal of Digestive Diseases|November 3, 2022
The neutrophil-to-lymphocyte ratio represents a systemic inflammation marker and reflects the relationship with 90-day mortality in non-cirrhotic chronic severe hepatitisFu Chen Dong, Wen Ting Tan, Xian Bo Wang, et al.
World Journal of Gastroenterology|September 26, 2022
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in ChinaZi-Xuan Shen, Dan-Dan Wu, Jie Xia, et al.
Eclinicalmedicine|February 24, 2023
Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort studyLi Yuan, Lin Yang, Shichuan Zhang, et al.
Pageof 70